country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-133906

Copy Link Print Information

AX13057

AX13057 is a KIAA1363 inhibitor with an IC₅₀ of 130 nM. AX13057 exhibits tumor penetration and is orally active. AX13057 can be used for research on ovarian cancer.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 1397274-79-1
Formel: C₁₆H₁₈BrNO₂
Molecular Weight:336.23

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

AX13057 Chemical Structure

CAS. Nr.: 1397274-79-1

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

AX13057 is a KIAA1363 inhibitor with an IC₅₀ of 130 nM. AX13057 exhibits tumor penetration and is orally active. AX13057 can be used for research on ovarian cancer^[1].

IC₅₀ & Target

^[1]

KIAA1363

130 nM (IC₅₀)

In Vivo

Anti-cancer

AX13057 (100 mg/kg; p.o. and i.p.) inhibits intratumoral KIAA1363 in SK-OV-3 xenograft-bearing female SCID mice, producing greater inhibition after i.p. dosing than after p.o. dosing^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

SCID (female)^[1]
Dosage:

100 mg/kg (p.o.); 100 mg/kg (i.p.)
Administration:

p.o.; i.p.
Result:

Inhibited tumor KIAA1363 by 22% after p.o. dosing with AX13057 at 100 mg/kg.
Inhibited intratumoral human KIAA1363 by 64% and mouse heart KIAA1363 by 66% after i.p. dosing with AX13057 at 100 mg/kg.

Chemical Information

CAS. Nr. 1397274-79-1
Molecular Weight 336.23
Formel C₁₆H₁₈BrNO₂
SMILES

O=C(OC=1C=CC2=CC(=CC=C2C1Br)CCC)N(C)C
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Shreder KR, et al. Synthesis and structure-activity relationship of (1-halo-2-naphthyl) carbamate-based inhibitors of KIAA1363 (NCEH1/AADACL1). Bioorganic & medicinal chemistry letters. 2012 Sep 01;22(17):5748-51. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen